摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,9-dihydro-6,7-dimethyl-5-nitro-4,9-dioxo-1H-naphtho-[2,3-d]-triazole | 72364-98-8

中文名称
——
中文别名
——
英文名称
4,9-dihydro-6,7-dimethyl-5-nitro-4,9-dioxo-1H-naphtho-[2,3-d]-triazole
英文别名
4,9-Dihydro-6,7-dimethyl-4,9-dioxo-5-nitronaphtho[2,3-d]-triazole;6,7-dimethyl-5-nitro-2H-benzo[f]benzotriazole-4,9-dione
4,9-dihydro-6,7-dimethyl-5-nitro-4,9-dioxo-1H-naphtho-[2,3-d]-triazole化学式
CAS
72364-98-8
化学式
C12H8N4O4
mdl
——
分子量
272.22
InChiKey
JIOKGODKMVWGKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    20
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    122
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2,3-dibromo-6,7-dimethylnaphthalene-1,4-dione盐酸 、 sodium dithionite 、 硫酸硝酸 、 sodium nitrite 作用下, 以 硝基苯 为溶剂, 反应 2.92h, 生成 4,9-dihydro-6,7-dimethyl-5-nitro-4,9-dioxo-1H-naphtho-[2,3-d]-triazole
    参考文献:
    名称:
    Studies on v-triazoles. 9. Antiallergic 4,9-dihydro-4,9-dioxo-1H-naphtho[2,3-d]-v-triazoles
    摘要:
    A short series of the title compounds was prepared and evaluated for antiallergic activity in the rat passive cutaneous anaphylaxis screen. All but the two N-methylated derivatives were active in this screen by the intravenous route, the most potent being the symmetrical dimethyl compound, 4,9-dihydro-6,7-dimethyl-4,9-dioxo-1H-naphtho[2,3-d]-v-triazole, and its 5-nitro derivative. The latter two compounds were noticeably more potent than disodium cromoglycate, and one of these, the unnitrated material, was selected for further evaluation as a potential antiasthmatic drug.
    DOI:
    10.1021/jm00359a016
点击查看最新优质反应信息

文献信息

  • 4,9-Dihydro-4,9-dioxo-1H-naphtho(2,3-d) triazoles, their preparation and antiallergic compositions containing them
    申请人:BEECHAM GROUP PLC
    公开号:EP0002310A1
    公开(公告)日:1979-06-13
    Compounds of formula (I): and pharmaceutically acceptable salts thereof wherein R1, R2, R3 and R4 which may be the same or different, represent hydrogen, halogen, nitro, lower alkyl, or lower alkoxy, or any adjacent two of R1 to R4 taken together represent an alkylene group containing from 3 to 5 carbon atoms or a 1,4-buta-1,3- dienylene group are disclosed together with a method for their preparation. The compounds are useful as anti-allergic agents. With the exception of 4,9-dioxo-1H-naphtho-[2,3-d]-triazole, and its salts, all compounds of formula (I) are novel.
    式(I)化合物:及其药学上可接受的盐,其中 R1、R2、R3 和 R4 可以相同或不同,代表氢、卤素、硝基、低级烷基或低级烷氧基,或 R1 至 R4 中任意相邻两个共同代表含有 3 至 5 个碳原子的亚烷基或 1,4-丁-1,3-二烯基。 这些化合物可用作抗过敏剂。 除 4,9-二氧代-1H-萘并-[2,3-d]-三唑及其盐类外,所有式(I)化合物均为新型化合物。
  • Process for preparing therapeutically active triazoles
    申请人:BEECHAM GROUP PLC
    公开号:EP0033214A2
    公开(公告)日:1981-08-05
    Process for the preparation of compounds of the formula (I): and pharmaceutically acceptable salts thereof wherein R1, R2, R3 and R4 which may be the same or different, represent hydrogen, halogen, nitro, lower alkyl or lower alkoxy, where lower means of up to six carbon atoms, or any adjacent two of R1 to R4 taken together represent an alkylene group containing from 3 to 5 carbon atoms or a 1,4-buta-1,3- dienylene group, by removal of CH2R5 wherein R5 is phenyl optionally substituted with one or two groups selected from C1-4 alkyl, C1-4 alkoxy, halogen or nitro from a compound of formula (II): with an alkali metal C1-4 primary alkoxide.
    制备式(I)化合物的工艺: 及其药学上可接受的盐 其中 R1、R2、R3 和 R4 可以相同或不同,代表氢、卤素、硝基、低级烷基或低级烷氧基,其中低级烷基是指最多 6 个碳原子的烷基,或 R1 至 R4 中任意相邻的两个共同代表含有 3 至 5 个碳原子的亚烷基或 1,4-丁-1,3-二烯基: 与碱金属 C1-4 伯烷氧基。
  • Process for preparing anti-allergy naphthotriazoles
    申请人:BEECHAM GROUP PLC
    公开号:EP0033215A2
    公开(公告)日:1981-08-05
    Process for the preparation of compounds of the formula (I): and pharmaceutically acceptable salts thereof wherein R1, R2, R3 and R4 which may be the same or different, represent hydrogen, halogen, nitro, lower alkyl or lower alkoxy, where lower means of up to six carbon atoms, or any adjacent two of R1 to R4 taken together represent an alkylene group containing from 3 to 5 carbon atoms or a 1,4-buta-1,3-dienylene group, by removing an N-protecting group Q from a compound of formula (II):
    制备式(I)化合物的工艺: 及其药学上可接受的盐 其中 R1、R2、R3 和 R4 可以相同或不同,代表氢、卤素、硝基、低级烷基或低级烷氧基,其中低级烷基是指最多六个碳原子的烷基,或 R1 至 R4 中任意相邻的两个共同代表含有 3 至 5 个碳原子的亚烷基或 1,4-丁-1,3-二烯基:
  • BUCKLE, D. R.;SMITH, H.;SPICER, B. A.;TEDDER, J. M., J. MED. CHEM., 1983, 26, N 5, 714-719
    作者:BUCKLE, D. R.、SMITH, H.、SPICER, B. A.、TEDDER, J. M.
    DOI:——
    日期:——
  • US4263309A
    申请人:——
    公开号:US4263309A
    公开(公告)日:1981-04-21
查看更多